Nanomedicine for Prostate Cancer Treatment
A Mobed, Z Sargazi, R Kheradmand, B Abdi… - BioNanoScience, 2024 - Springer
Prostate cancer (PrC) is the most common cancer—after skin cancer—and the fifth most
aggressive neoplasm among men worldwide. In most cases, PrC grow slowly and are …
aggressive neoplasm among men worldwide. In most cases, PrC grow slowly and are …
Exploring the interplay between the TGF-β pathway and SLN-mediated transfection: implications for gene delivery efficiency in prostate cancer and non-cancer cells
T Moraes-Lacerda, F Garcia-Fossa… - Nanotechnology, 2024 - iopscience.iop.org
Solid lipid nanoparticles (SLN) are widely recognized for their biocompatibility, scalability,
and long-term stability, making them versatile formulations for drug and gene delivery …
and long-term stability, making them versatile formulations for drug and gene delivery …